Patent · US Active

Method of treating sensorimotor disorders with alpha-2 adrenergic receptor agonists

US8455548B2 · kind B2 · utility

5Cited by
16References
2Claims
0Family size

Assignee

Inventors

Key dates

Filing dateOct 14, 2008
Grant dateJun 4, 2013
Priority date
Expiry dateDec 15, 2028

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P25/30
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Disclosed herein is a method of treating sensorimotor disorders comprising administering to a subject in need of such treatment an alpha-2 receptor agonist lacking significant alpha-2A receptor activity.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.